Explore peer-reviewed research articles, clinical trials, and molecular pathways in inflammatory diseases
Discover how Yaq-001, a non-absorbable gut-restricted adsorbent, is revolutionizing cirrhosis treatment by targeting the gut-liver axis and intercepting toxins before they damage the liver.